Federal Register #DEA1751

DEA Notice: Curia New York Inc Application for Bulk Manufacturing of Controlled Substances

This opportunity concerns Curia New York Inc's application to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of controlled substances. - Government Buyer: - Drug Enforcement Administration (DEA), U.S. Department of Justice - OEM/Vendor: - Curia New York Inc - Products/Services Requested: - Bulk manufacturing of controlled substances as active pharmaceutical ingredients - Gamma Hydroxybutyric Acid (drug code 2010, Schedule I) - Marihuana (drug code 7360, Schedule I; synthetic manufacture only) - Tetrahydrocannabinols (drug code 7370, Schedule I; synthetic manufacture only) - Amphetamine (drug code 1100, Schedule II) - Lisdexamfetamine (drug code 1205, Schedule II) - Methylphenidate (drug code 1724, Schedule II) - Pentobarbital (drug code 2270, Schedule II) - 4-Anilino-N-phenethyl-4-piperidine (ANPP, drug code 8333, Schedule II) - Unique/Notable Requirements: - Registration is for bulk manufacturing only; no other activities authorized for these drug codes - Marihuana and Tetrahydrocannabinols must be manufactured synthetically - Public comments and hearing requests are invited regarding the application - Purpose: - Manufacture bulk active pharmaceutical ingredients for product development and distribution

Description

Curia New York Inc has applied to be registered as a bulk manufacturer of basic classes of controlled substances. The company plans to manufacture these controlled substances as bulk active pharmaceutical ingredients for use in product development and distribution to customers. Specifically, for Marihuana and Tetrahydrocannabinols, the company plans to manufacture these drugs synthetically. Comments on the application are due by October 26, 2026, and requests for a hearing can also be filed by this date.

View original listing